Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.

Live Updates Live Coverage Has Ended CEO on Conference Call 5:06 pm Updates from CEO Irwin Simon on tonight’s call: ...

Tilray Brands Inc (TLRY) reports a robust quarter with significant international growth and improved financial metrics ...

Stock futures edged higher Tuesday morning as investors weighed renewed U.S.-China trade talks and looked ahead to a busy ...

Cannabis company Tilray Brands (NASDAQ:TLRY) in Q2 CY2025, with sales falling 2.3% year on year to $224.5 million. Its GAAP ...

Tilray Brands Inc (NASDAQ: TLRY) soared more than 15% today as retail investors continued to grow their positions in the ...

Tilray's fiscal Q4 results disappointed, with revenues missing estimates and a massive $1.26B net loss driven by impairment ...

Shares of Tilray are trading lower Tuesday morning. The company reported Q4 revenue that fell short of analyst expectations.

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Tilray announces fiscal fourth-quarter revenue of $224.53 million, missing analyst estimates of $250.41 million, according to Benzinga Pro.

As the marijuana market grows more competitive, some retailers are shifting how they present their products to customers. These changes, going beyon ...

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.